Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Maura, Gillison"'
Autor:
Maura Gillison, Rafet Basar, Vakul Mohanty, Ken Chen, Hind Rafei, Katayoun Rezvani, Shan He, Xianli Jiang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/ace59b731b1949ceb67539275b19321f
Autor:
Li Wang, MD, PhD, Piero Fossati, MD, Harald Paganetti, PhD, Li Ma, PhD, Maura Gillison, MD, PhD, Jeffrey N. Myers, MD, PhD, Eugen Hug, MD, Steven J. Frank, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 1, Pp 3-13 (2021)
Head and neck squamous cell carcinomas (HNSCCs) often present as local-regionally advanced disease at diagnosis, for which a current standard of care is x-ray–based radiation therapy, with or without chemotherapy. This approach provides effective l
Externí odkaz:
https://doaj.org/article/63a22265bc0541dea3a22b24e0e927a1
Autor:
Houda Bahig, MD, PhD, Brandon G. Gunn, MD, Adam S. Garden, MD, Rong Ye, MSc, Kate Hutcheson, PhD, David I. Rosenthal, MD, Jack Phan, MD, PhD, Clifton D. Fuller, MD, PhD, William H. Morrison, MD, PhD, Jay Paul Reddy, MD, PhD, Sweet Ping Ng, MBBS, FRANZCR, Neil D. Gross, MD, Erich M. Sturgis, MD, MPH, Renata Ferrarotto, MD, Maura Gillison, MD, PhD, Steven J. Frank, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 1, Pp 213-222 (2021)
Purpose: To report patient-reported outcomes (PROs) derived from the Functional Assessment of Cancer Therapy-Head and Neck (FACT-HN) tool, in patients with oropharynx cancer (OPC) treated with intensity-modulated proton therapy (IMPT) in the context
Externí odkaz:
https://doaj.org/article/7798306b9caa467e856f1cf6299fe00c
Autor:
Thomas Davis, Jessica Price, Mark Awad, Ammar Sukari, Roger Cohen, Mark Stein, Przemyslaw Twardowski, Jessica Flechtner, Melissa Johnson, Maura Gillison, Rudy Lackner, Arthur DeCillis, Richard Hernandez, Kevin Mancini, Mara Shainheit, Gabriella Santone, Syukri Shukor, Ece Bicak, Vijetha Vemulapalli, Emily Tjon
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/b438e17ae0984433ad0a4a78c3a52d0c
Autor:
Linghua Wang, Jeffrey Myers, Michelle Williams, Alexandre Reuben, Michael Curran, Neil Gross, Diana Bell, Xiuning Le, Maura Gillison, Minghao Dang, Amit Agrawal, Stephen Lai, Ryan Goepfert, Qianyun Luo, Ravaen Slay, Venkatesh Hegde, Weihong Xiao, Keiko Akagi, Joseph Fresquez, Kathrina Marcelo, Pragya Sinha, Ananta Yanamandra, Edwin Parra Cuentas, Jagannadha Sastry
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/1c3d1499abc047e3af293089c60c7bf9
Autor:
Robert I. Haddad, Kevin Harrington, Makoto Tahara, Robert L. Ferris, Maura Gillison, Jerome Fayette, Amaury Daste, Piotr Koralewski, Bogdan Zurawski, Miren Taberna, Nabil F. Saba, Milena Mak, Andrzej Kawecki, Gustavo Girotto, Miguel Angel Alvarez Avitia, Caroline Even, Joaquin Gabriel Reinoso Toledo, Alexander Guminski, Urs Müller-Richter, Naomi Kiyota, Mustimbo Roberts, Tariq Aziz Khan, Karen Miller-Moslin, Li Wei, Athanassios Argiris
Publikováno v:
Journal of Clinical Oncology. 41:2166-2180
PURPOSE CheckMate 651 (ClinicalTrials.gov identifier: NCT02741570 ) evaluated first-line nivolumab plus ipilimumab versus EXTREME (cetuximab plus cisplatin/carboplatin plus fluorouracil ≤ six cycles, then cetuximab maintenance) in recurrent/metasta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea41d080266110a8825a284e080af38
https://doi.org/10.1200/jco.22.00332
https://doi.org/10.1200/jco.22.00332
Autor:
Trisha Wise-Draper, Diana Bell, Roman Jandarov, Shuchi Gulati, Maura Gillison, Vinita Takiar, Sarah Palackdharry, Francis Worden, Matthew Old, John Kaczmar, Neal Dunlap, Benjamin Hinrichs, Yash Patil, Muhammad Kashif Riaz, Layne Weatherford, Aubrey Hamilton, Sheena Lanverman, Michelle Mierzwa, Keith Casper, Jonathan Mark, Alice Tang, Chad Zender, Ann Gillenwater, Mario Medvedovich, J Jack Lee
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/c8ca5e636a384d40ae1ebb2c7416d267
Autor:
Siqing Fu, Daniel Karp, Maura Gillison, Anjali Raina, Brent Kreider, David Tung, Mary Varterasian, Khashayarsha Khazaie
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/ba48607310d4483681b7e8a606847402
Autor:
Thomas Davis, Jessica Price, Ammar Sukari, Roger Cohen, Przemyslaw Twardowski, Jessica Flechtner, Melissa Johnson, Maura Gillison, Rudy Lackner, Arthur DeCillis, Richard Hernandez, Kevin Mancini, Mara Shainheit
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/26d2fd7d8bed4b769e10d720e04ce8c6
Autor:
Cherie-Ann O. Nathan, D. Neil Hayes, Theodore Karrison, Olivier Harismendy, José M. Flores, Tara Moore-Medlin, Everett E. Vokes, J. Silvio Gutkind, Prakash Neupane, Glenn Mills, Zoukaa Sargi, Tanguy Seiwert, Juneko Grilley-Olson, Terry Day, Maura Gillison, James L. Wade, Lawrence Feldman, Gautam Jha, Mark Kozloff, Miriam O'Leary, Francis P. Worden, Ezra E.W. Cohen
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 28, iss 23
Clin Cancer Res
Clin Cancer Res
Purpose: Investigate whether adjuvant everolimus, an mTOR inhibitor, improves progression-free survival (PFS) in advanced-stage head and neck squamous cell carcinoma (HNSCC) and provide outcomes related to correlative biological factors associated wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0370f301ad46efff6a4eb5a25479bea5
https://doi.org/10.1158/1078-0432.ccr-21-4290
https://doi.org/10.1158/1078-0432.ccr-21-4290